RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Research and Development

A collection of news and information related to Research and Development published by this site and its partners.

Top Research and Development Articles

Displaying items 1-11
  • The increasing irrelevance of corporate nationality [Commentary]

    The increasing irrelevance of corporate nationality [Commentary]
    "You shouldn't get to call yourself an American company only when you want a handout from the American taxpayers," President Obama said last week. He was referring to American corporations now busily acquiring foreign companies in order to become non-...
  • Robert B. Reich: The increasing irrelevance of corporate nationality

    "You shouldn't get to call yourself an American company only when you want a handout from the American taxpayers," President Obama said last week. He was referring to American corporations now busily acquiring foreign companies in order to become non-...
  • Allergan employees, Irvine officials worried over Valeant offer

    Allergan employees, Irvine officials worried over Valeant offer
    Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
  • Most of Allergan's 1,500 job cuts will be in Southern California

    Most of Allergan's 1,500 job cuts will be in Southern California
    Most of the 1,500 job cuts that Botox maker Allergan Inc. announced Monday morning will be made in Southern California, the company’s chief executive said. Allergan plans to eliminate 650 research and development jobs, the bulk of them at its...
  • One-third of Panduit compound under renovation

    One-third of Panduit compound under renovation
    One of the industrial-looking buildings at Panduit's compound at 175th Street and Ridgeland Avenue in Tinley Park will be sporting a more modern look this year, if all goes according to plan. But the fate of the rest of the 65-acre property remains...
  • Regional additive manufacturing authority established in Harford

    Gov. Martin O'Malley signed a bill Thursday creating a regional 3D printing and additive manufacturing authority in collaboration with the Edgewood Chemical Biological Center at Aberdeen Proving Ground. The bill, creating the Northeast Maryland Additive...
  • Pfizer's interest in AstraZeneca worries Maryland

    Pfizer's interest in AstraZeneca worries Maryland
    Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina. Maryland officials don't want this state to join that list. After Pfizer declared its desire to buy AstraZeneca — which...
  • STX goes global, expands into ice hockey

    STX goes global, expands into ice hockey
    Athletes associate STX with lacrosse, but the Baltimore-based brand began appearing last month in stores on ice hockey sticks and plans to launch a line of men's field hockey sticks in the United Kingdom. For the 44-year-old inventor of the modern...
  • Allergan questions viability, experience of would-be buyer Valeant

    A day before would-be buyer Valeant Pharmaceuticals is set to unveil a second, unsolicited takeover bid, its acquisition target, Allergan Inc., sought to discredit the company by filing a presentation with regulators questioning the viability of Valeant's...
  • Allergan steps up attack on Valeant

    The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack. On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...